Geneus
Chengdu
About Geneus
Geneus develops and commercializes gene sequencers and reagents. The core of its technology is based on the characteristic current signal generated by the interaction of protein nanopores and nucleic acid bases, and it realizes single-molecule nucleic acid sequencing through an integrated chip system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $13.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2025)
- Website: geneus-tech.com
- Phone: +86 028-87455350
Industries & Categories
Application Specific Integrated Circuit (ASIC), Bioinformatics, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/geneus-148210 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.